We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
26
Union Pacific
UNP
$183B
$71.6M 0.96%
657,243
+85,314
+15% +$9.3M
JPM icon
27
JPMorgan Chase
JPM
$939B
$68.6M 0.92%
750,937
-7,170
-0.9% -$619K
ABT icon
28
Abbott
ABT
$180B
$68.3M 0.92%
1,405,917
+595,917
+74% +$27M
UNH icon
29
UnitedHealth
UNH
$382B
$67.9M 0.91%
366,300
+44,800
+14% +$7.86M
SPGI icon
30
S&P Global
SPGI
$126B
$66.9M 0.9%
458,520
+49,252
+12% +$6.84M
AET
31
DELISTED
Aetna Inc
AET
$64.9M 0.87%
427,276
+39,764
+10% +$5.62M
PFE icon
32
Pfizer
PFE
$140B
$64.4M 0.87%
2,021,511
-891,684
-31% -$28.1M
AMD icon
33
CALL
Advanced Micro Devices
AMD
$851B
$64.4M 0.87%
5,159,000
+3,200,000
+163% +$39.1M
WFC icon
34
Wells Fargo
WFC
$261B
$62M 0.83%
1,119,214
-4,182
-0.4% -$224K
DHR icon
35
Danaher
DHR
$135B
$60.1M 0.81%
803,768
+522,896
+186% +$39.1M
BAC icon
36
Bank of America
BAC
$435B
$58.7M 0.79%
2,418,940
+266,701
+12% +$6.22M
AMAT icon
37
Applied Materials
AMAT
$426B
$58.5M 0.79%
1,416,035
+60,376
+4% +$2.57M
SU icon
38
Suncor Energy
SU
$77.7B
$58.2M 0.78%
1,723,237
-272,566
-14% -$8.38M
BDX icon
39
Becton Dickinson
BDX
$43.1B
$57.9M 0.78%
304,114
+283,614
+1,383% +$51.8M
DOX icon
40
Amdocs
DOX
$5.53B
$56M 0.75%
869,056
-10,262
-1% -$648K
AMD icon
41
Advanced Micro Devices
AMD
$851B
$54.1M 0.73%
4,332,533
+1,193,949
+38% +$14.6M
RTX icon
42
RTX Corp
RTX
$287B
$52.4M 0.71%
+681,946
New +$51.1M
KEX icon
43
Kirby Corp
KEX
$7.95B
$52.4M 0.7%
783,392
+83,503
+12% +$5.69M
CI icon
44
Cigna
CI
$76.6B
$51.3M 0.69%
306,268
+161,144
+111% +$25.9M
NEWR
45
DELISTED
New Relic, Inc.
NEWR
$50.8M 0.68%
1,180,693
+28,624
+2% +$1.19M
ZEN
46
DELISTED
ZENDESK INC
ZEN
$49.6M 0.67%
1,785,830
-91,704
-5% -$2.52M
REGN icon
47
Regeneron Pharmaceuticals
REGN
$68.8B
$48.5M 0.65%
98,763
+70,763
+253% +$31M
HUM icon
48
Humana
HUM
$46.7B
$47M 0.63%
+195,436
New +$44.2M
Y
49
DELISTED
Alleghany Corp
Y
$46.2M 0.62%
77,750
+1,400
+2% +$833K
OLED icon
50
Universal Display
OLED
$3.71B
$44.7M 0.6%
409,320
-23,059
-5% -$2.43M
1
2
3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.